期刊文献+

贝那普利联合氯沙坦对环孢素A致大鼠慢性肾毒性的防治作用 被引量:3

Preventive effects of benopril and losartan on cyclosporine A chronic nephrotoxicity in rats
下载PDF
导出
摘要 目的:探讨贝那普利和氯沙坦防治环孢素A(CsA)慢性肾毒性的疗效及作用机制。方法:50只SD大鼠随机分为对照组、模型组、贝那普利组、氯沙坦组、联合用药组,每组10只。低盐饲料饲养,以CsA15mg/(kg.d)皮下注射造模,贝那普利组、氯沙坦组、联合用药组分别以单用贝那普利、氯沙坦及两者联用灌胃治疗,对照组和模型组以同体积生理盐水灌胃。于第4周末处死动物,取肾脏作肾组织血管紧张素Ⅱ(AngⅡ)含量测定,Masson染色检测肾脏纤维化,免疫组织化学方法检测生长转化因子-β1(TGF-β1)和胶原Ⅲ(ColⅢ)的表达情况。结果:与对照组相比,模型组的肾组织AngⅡ含量、间质纤维化程度、TGF-β1、ColⅢ明显升高;单药治疗组间质纤维化程度、TGF-β1、ColⅢ较模型组均有所下降,联合用药组低于单药治疗组,差异均有统计学意义(P<0.05)。结论:贝那普利和氯沙坦可能是通过下调TGF-β1,抑制ColⅢ表达,从而延缓CsA大鼠肾间质纤维化进展。两者联合应用,疗效更显著。 Aim : To investigate the effect of benopril and losartan on CsA chronic nephrotoxicity. Methods:Fifty rats were allocated into control group, model group, benopril group, losartan group and benopril and losartan combination group randomly. With lower-salt diet, model rat was established by CsA ( 15 rag/( kg · d) ) , meanwhile, normal saline,benopril, losartan,or combination of benopril and losartan was given to rats in these groups. At the end of 4 weeks, kidneys were harvested. Ang Ⅱ was determined by immunoradiometry. Masson staining was performed, as well as TGF-β1 and Col m were determined by immunohistochemistry. Results:The degree of fibrosis, Ang Ⅱ,TGF-β1, and Col m in model group were significantly higher than control group. The degree of fibrosis,TGF-β1, and Col m in benopril group or losartan group decreased compared with model group. The parameters in the combination group were lower than those in benopril group or losartan group(P 〈0.05). Conclusion:Combination of benopril and losartan attenuate fibrosis in interstitial by down-regulating expression of TGF-β1 and Colin. The effect of combination of benopril and losartan is better than that of benopril or losartan.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2007年第6期1055-1057,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关基金资助项目0324410084 河南省杰出青年基金资助项目74100510006
关键词 贝那普利 氯沙坦 环孢素A 肾毒性 大鼠 benopril losartan cyclosporine A nephrotoxicity rat
  • 相关文献

参考文献8

二级参考文献19

  • 1[1]Tsuzuki K. Role of mizoribine in renal transplantation[J]. Pediatr Int,2002,44(3):224-231.
  • 2[2]Clipstone N A,Crabtree G R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation[J].Nature,1992,357(6 380):695-697.
  • 3[3]Weir M R,Ward M T,Blahut S A,et al. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy[J]. Kidney Int,2001,59(11):1 567-1 573.
  • 4[4]Olyaei A J,de Mattos A M,Bennett W M. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies[J]. Curr Opin Crit Care,2001,7(4):384-389.
  • 5[5]Weir M R. Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation[J]. Transplant Proc,2001,33:19S-28S.
  • 6[6]Mele T S,Halloran P F. The use of mycophenolate mofetil in transplant recipients[J]. Immunopharmacology,2000,47(3):215-245.
  • 7[7]Tran H B,Acharya M K,Mckay D B,et al. Avoidance of cyclosporine in renal transplantation:effects of daclizumab,mycophenolate mofetil,and steroids[J]. J Am Soc Nephrol,2000,11:1 903-1 909.
  • 8Border WA, Noble NA. TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int, 1997, 51: 1388-1397.
  • 9Riser BL, Denichilo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol, 2000, 11: 25-38.
  • 10Heusinger RJ, Eberlein M, Wahab NA, et al. Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and camp.J Am Soc Nephrol, 2001, 12: 1853-1861.

共引文献27

同被引文献22

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部